Characteristics, Mortality, and Clinical Outcomes of Hospitalized Patients with COVID-19 and Diabetes: A Reference Single-Center Cohort Study from Poland

Background. Diabetes is a risk factor for a severe course of COVID-19. We evaluated the characteristics and risk factors associated with undesirable outcomes in diabetic patients (DPs) hospitalized due to COVID-19. Materials and Methods. The data analysis of patients admitted between March 6, 2020,...

Full description

Saved in:
Bibliographic Details
Main Authors: Michał Kania, Konrad Mazur, Michał Terlecki, Bartłomiej Matejko, Jerzy Hohendorff, Zlata Chaykivska, Mateusz Fiema, Marianna Kopka, Małgorzata Kostrzycka, Magdalena Wilk, Tomasz Klupa, Przemysław Witek, Barbara Katra, Marek Klocek, Marek Rajzer, Maciej T. Malecki
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2023/8700302
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832548837427773440
author Michał Kania
Konrad Mazur
Michał Terlecki
Bartłomiej Matejko
Jerzy Hohendorff
Zlata Chaykivska
Mateusz Fiema
Marianna Kopka
Małgorzata Kostrzycka
Magdalena Wilk
Tomasz Klupa
Przemysław Witek
Barbara Katra
Marek Klocek
Marek Rajzer
Maciej T. Malecki
author_facet Michał Kania
Konrad Mazur
Michał Terlecki
Bartłomiej Matejko
Jerzy Hohendorff
Zlata Chaykivska
Mateusz Fiema
Marianna Kopka
Małgorzata Kostrzycka
Magdalena Wilk
Tomasz Klupa
Przemysław Witek
Barbara Katra
Marek Klocek
Marek Rajzer
Maciej T. Malecki
author_sort Michał Kania
collection DOAJ
description Background. Diabetes is a risk factor for a severe course of COVID-19. We evaluated the characteristics and risk factors associated with undesirable outcomes in diabetic patients (DPs) hospitalized due to COVID-19. Materials and Methods. The data analysis of patients admitted between March 6, 2020, and May 31, 2021, to the University Hospital in Krakow (Poland), a reference center for COVID-19, was performed. The data were gathered from their medical records. Results. A total number of 5191 patients were included, of which 2348 (45.2%) were women. The patients were at the median age of 64 (IQR: 51–74) years, and 1364 (26.3%) were DPs. DPs, compared to nondiabetics, were older (median age: 70 years, IQR: 62–77 vs. 62, IQR: 47–72, and p < 0.001) and had a similar gender distribution. The DP group had a higher mortality rate (26.2% vs. 15.7%, p < 0.001) and longer hospital stays (median: 15 days, IQR: 10–24 vs. 13, IQR: 9–20, and p < 0.001). DPs were admitted to the ICU more frequently (15.7% vs. 11.0%, p < 0.001) and required mechanical ventilation more often (15.5% vs. 11.3%, p < 0.001). In a multivariate logistic regression, factors associated with a higher risk of death were age >65 years, glycaemia >10 mmol/L, CRP and D-dimer level, prehospital insulin and loop diuretic use, presence of heart failure, and chronic kidney disease. Factors contributing to lower mortality were in-hospital use of statin, thiazide diuretic, and calcium channel blocker. Conclusion. In this large COVID-19 cohort, DPs constituted more than a quarter of hospitalized patients. The risk of death and other outcomes compared to nondiabetics was higher in this group. We identified a number of clinical, laboratory, and therapeutic variables associated with the risk of hospital death in DPs.
format Article
id doaj-art-a3b2e3f7205d45359a55b207b3629fb7
institution Kabale University
issn 1687-8345
language English
publishDate 2023-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-a3b2e3f7205d45359a55b207b3629fb72025-02-03T06:12:58ZengWileyInternational Journal of Endocrinology1687-83452023-01-01202310.1155/2023/8700302Characteristics, Mortality, and Clinical Outcomes of Hospitalized Patients with COVID-19 and Diabetes: A Reference Single-Center Cohort Study from PolandMichał Kania0Konrad Mazur1Michał Terlecki2Bartłomiej Matejko3Jerzy Hohendorff4Zlata Chaykivska5Mateusz Fiema6Marianna Kopka7Małgorzata Kostrzycka8Magdalena Wilk9Tomasz Klupa10Przemysław Witek11Barbara Katra12Marek Klocek13Marek Rajzer14Maciej T. Malecki15Department of Metabolic Diseases and DiabetologyUniversity Hospital in KrakowUniversity Hospital in KrakowDepartment of Metabolic Diseases and DiabetologyDepartment of Metabolic Diseases and DiabetologyUniversity Hospital in KrakowUniversity Hospital in KrakowUniversity Hospital in KrakowUniversity Hospital in KrakowDepartment of Metabolic Diseases and DiabetologyDepartment of Metabolic Diseases and DiabetologyDepartment of Metabolic Diseases and DiabetologyDepartment of Metabolic Diseases and DiabetologyUniversity Hospital in KrakowUniversity Hospital in KrakowDepartment of Metabolic Diseases and DiabetologyBackground. Diabetes is a risk factor for a severe course of COVID-19. We evaluated the characteristics and risk factors associated with undesirable outcomes in diabetic patients (DPs) hospitalized due to COVID-19. Materials and Methods. The data analysis of patients admitted between March 6, 2020, and May 31, 2021, to the University Hospital in Krakow (Poland), a reference center for COVID-19, was performed. The data were gathered from their medical records. Results. A total number of 5191 patients were included, of which 2348 (45.2%) were women. The patients were at the median age of 64 (IQR: 51–74) years, and 1364 (26.3%) were DPs. DPs, compared to nondiabetics, were older (median age: 70 years, IQR: 62–77 vs. 62, IQR: 47–72, and p < 0.001) and had a similar gender distribution. The DP group had a higher mortality rate (26.2% vs. 15.7%, p < 0.001) and longer hospital stays (median: 15 days, IQR: 10–24 vs. 13, IQR: 9–20, and p < 0.001). DPs were admitted to the ICU more frequently (15.7% vs. 11.0%, p < 0.001) and required mechanical ventilation more often (15.5% vs. 11.3%, p < 0.001). In a multivariate logistic regression, factors associated with a higher risk of death were age >65 years, glycaemia >10 mmol/L, CRP and D-dimer level, prehospital insulin and loop diuretic use, presence of heart failure, and chronic kidney disease. Factors contributing to lower mortality were in-hospital use of statin, thiazide diuretic, and calcium channel blocker. Conclusion. In this large COVID-19 cohort, DPs constituted more than a quarter of hospitalized patients. The risk of death and other outcomes compared to nondiabetics was higher in this group. We identified a number of clinical, laboratory, and therapeutic variables associated with the risk of hospital death in DPs.http://dx.doi.org/10.1155/2023/8700302
spellingShingle Michał Kania
Konrad Mazur
Michał Terlecki
Bartłomiej Matejko
Jerzy Hohendorff
Zlata Chaykivska
Mateusz Fiema
Marianna Kopka
Małgorzata Kostrzycka
Magdalena Wilk
Tomasz Klupa
Przemysław Witek
Barbara Katra
Marek Klocek
Marek Rajzer
Maciej T. Malecki
Characteristics, Mortality, and Clinical Outcomes of Hospitalized Patients with COVID-19 and Diabetes: A Reference Single-Center Cohort Study from Poland
International Journal of Endocrinology
title Characteristics, Mortality, and Clinical Outcomes of Hospitalized Patients with COVID-19 and Diabetes: A Reference Single-Center Cohort Study from Poland
title_full Characteristics, Mortality, and Clinical Outcomes of Hospitalized Patients with COVID-19 and Diabetes: A Reference Single-Center Cohort Study from Poland
title_fullStr Characteristics, Mortality, and Clinical Outcomes of Hospitalized Patients with COVID-19 and Diabetes: A Reference Single-Center Cohort Study from Poland
title_full_unstemmed Characteristics, Mortality, and Clinical Outcomes of Hospitalized Patients with COVID-19 and Diabetes: A Reference Single-Center Cohort Study from Poland
title_short Characteristics, Mortality, and Clinical Outcomes of Hospitalized Patients with COVID-19 and Diabetes: A Reference Single-Center Cohort Study from Poland
title_sort characteristics mortality and clinical outcomes of hospitalized patients with covid 19 and diabetes a reference single center cohort study from poland
url http://dx.doi.org/10.1155/2023/8700302
work_keys_str_mv AT michałkania characteristicsmortalityandclinicaloutcomesofhospitalizedpatientswithcovid19anddiabetesareferencesinglecentercohortstudyfrompoland
AT konradmazur characteristicsmortalityandclinicaloutcomesofhospitalizedpatientswithcovid19anddiabetesareferencesinglecentercohortstudyfrompoland
AT michałterlecki characteristicsmortalityandclinicaloutcomesofhospitalizedpatientswithcovid19anddiabetesareferencesinglecentercohortstudyfrompoland
AT bartłomiejmatejko characteristicsmortalityandclinicaloutcomesofhospitalizedpatientswithcovid19anddiabetesareferencesinglecentercohortstudyfrompoland
AT jerzyhohendorff characteristicsmortalityandclinicaloutcomesofhospitalizedpatientswithcovid19anddiabetesareferencesinglecentercohortstudyfrompoland
AT zlatachaykivska characteristicsmortalityandclinicaloutcomesofhospitalizedpatientswithcovid19anddiabetesareferencesinglecentercohortstudyfrompoland
AT mateuszfiema characteristicsmortalityandclinicaloutcomesofhospitalizedpatientswithcovid19anddiabetesareferencesinglecentercohortstudyfrompoland
AT mariannakopka characteristicsmortalityandclinicaloutcomesofhospitalizedpatientswithcovid19anddiabetesareferencesinglecentercohortstudyfrompoland
AT małgorzatakostrzycka characteristicsmortalityandclinicaloutcomesofhospitalizedpatientswithcovid19anddiabetesareferencesinglecentercohortstudyfrompoland
AT magdalenawilk characteristicsmortalityandclinicaloutcomesofhospitalizedpatientswithcovid19anddiabetesareferencesinglecentercohortstudyfrompoland
AT tomaszklupa characteristicsmortalityandclinicaloutcomesofhospitalizedpatientswithcovid19anddiabetesareferencesinglecentercohortstudyfrompoland
AT przemysławwitek characteristicsmortalityandclinicaloutcomesofhospitalizedpatientswithcovid19anddiabetesareferencesinglecentercohortstudyfrompoland
AT barbarakatra characteristicsmortalityandclinicaloutcomesofhospitalizedpatientswithcovid19anddiabetesareferencesinglecentercohortstudyfrompoland
AT marekklocek characteristicsmortalityandclinicaloutcomesofhospitalizedpatientswithcovid19anddiabetesareferencesinglecentercohortstudyfrompoland
AT marekrajzer characteristicsmortalityandclinicaloutcomesofhospitalizedpatientswithcovid19anddiabetesareferencesinglecentercohortstudyfrompoland
AT maciejtmalecki characteristicsmortalityandclinicaloutcomesofhospitalizedpatientswithcovid19anddiabetesareferencesinglecentercohortstudyfrompoland